8-K
Current Report
RIGEL PHARMACEUTICALS INC Filed Acc 0001104659-12-040165
Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading a12-13153_18k.htm…